The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing
to disrupt personal lives, global healthcare systems, and economies. Hence, there is an …

Background Emerging and future SARS-CoV-2 variants may jeopardize the effectiveness of
vaccination campaigns. Therefore, it is important to know how the different vaccines perform …

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …

The Lassa virus is endemic in parts of West Africa, and it causes hemorrhagic fever with high
mortality. The development of a recombinant protein vaccine has been hampered by the …

Delineating the origins and properties of antibodies elicited by SARS-CoV-2 infection and
vaccination is critical for understanding their benefits and potential shortcomings. Therefore, …

… Marloes Grobben … Keuning and Marloes Grobben contributed equally to this article.
Author order was determined on the basis of contributions to study conception and design. …

Highlights • Therapy combining two or more antibodies show promising results in clinical
trials. • Fc domain engineering can improve antibody half-life and enhance effector function. • …

Background Patients with inborn errors of immunity (IEI) are at increased risk of severe
coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of …

Current SARS-CoV-2 vaccines are effective, but long-term protection is threatened by the
emergence of virus variants. We generated a virosome vaccine containing the Beta spike …

Objectives Preventive measures against COVID-19 are essential for pregnant women. Pregnant
women are particularly vulnerable to emerging infectious pathogens due to alterations …